About Ignoxlabs Private Limited
Data last updated: 05 January 2026
Ignoxlabs Private Limited is a private limited company based in Gurgaon, Haryana, India, a subsidiary of Agarsha Senior Care Private Limited and recognised as a startup by DPIIT. It specialises in online healthcare services, a part of the broader internet and digital services sector. Incorporated on 06 July 2017, the company has been in operation for over 9 years.
Registered with ROC Delhi under CIN U85100HR2017PTC069799.
Capital: an authorised share capital of ₹30 Cr and a paid-up capital of ₹28.59 Cr. It is led by directors including Saumyajit Roy and Manreet Kahlon.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 2Nd Floor Unit No. 216 Ocus Quantum Sector 51, Gurgaon, Haryana, India – 122003.
As per the financials filed for FY 2025, the company reported a revenue of ₹68.03 Cr, a growth of 54% compared to the previous year.
The company has a workforce of approximately 357 employees as per the latest available data. It operates as a subsidiary of Agarsha Senior Care Private Limited.
The company is associated with 1 brand - Emoha.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website emoha.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Apps
-
Registered Address2Nd Floor Unit No. 216 Ocus Quantum Sector 51, Gurgaon, Haryana, India – 122003
-
IndustryInternet, Online Healthcare Services
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Ignoxlabs Private Limited
Ignoxlabs Private Limited has one previous CIN (Corporate Identification Number): U74999HR2017PTC069799. The current CIN is U85100HR2017PTC069799, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85100HR2017PTC069799 | Current |
| U74999HR2017PTC069799 | Previous |
Associated Brands with Ignoxlabs Private Limited
Ignoxlabs Private Limited operates one associated brand: Emoha. These brands represent Ignoxlabs Private Limited's diversified market presence and brand portfolio.
Competitors & Alternatives of Ignoxlabs Private Limited
Brands and companies operating in the same space as Ignoxlabs Private Limited include Yodda, Tribeca Care, LifeCircle and 5 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Yodda
|
Provider of elder care services at home | Pune, India, India | 2021 |
Tribeca Care
|
Provider of an on-demand home healthcare services for elders | Kolkata, India, India | 2013 |
LifeCircle
|
Home healthcare services for elderly needs | Hyderabad, India, India | 2013 |
Vesta Elder Care
|
Home care services such as nursing and physiotherapy are provided. | Delhi, India, India | 2016 |
Happy60plus
|
Home healthcare and wellness services for the elderly are provided. | Bengaluru, India, India | 2019 |
Anvayaa
|
Home healthcare services for elders are delivered via online platform. | Hyderabad, India, India | 2016 |
60plusindia.com
|
Healthcare services for elders are delivered via an online platform. | Chennai, India, India | 2021 |
Aaji Care
|
Provides dementia care, home patient services, and assisted living for seniors. | Mumbai, India, India | 2014 |
Business Activity of Ignoxlabs Private Limited
Ignoxlabs Private Limited is engaged in the principal business activity of hospital and medical care, with detailed activities including residential care for elderly, disabled and other ailments.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q4 | Residential care for elderly, disabled and other ailments | ********* |
Auditor Details of Ignoxlabs Private Limited
Ignoxlabs Private Limited is audited by S.N. Dhawan & CO LLP for the financial year 2025. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S.N. Dhawan & CO LLP | blur-value | blur-value | blur-value |
Board of Directors of Ignoxlabs Private Limited
Ignoxlabs Private Limited is currently managed by 4 directors, with 3 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Saumyajit Roy
Also directs:
Ignoxlabs Private Limited, Agarsha Senior Homes Private Limited, Epoch Elder Care Private Limited and 1 more
|
Director | 30 Apr 2018 | 8 Years 2 Months | Current |
|
Manreet Kahlon
Also directs:
Ignoxlabs Private Limited, Navio Health Private Limited
|
Director | 30 Sep 2019 | 6 Years 9 Months | Current |
|
Harsh Kumar Singh
Also directs:
Ignoxlabs Private Limited
|
Director | 30 Sep 2019 | 6 Years 9 Months | Current |
Financials of Ignoxlabs Private Limited FY 2025 filings available
Ignoxlabs Private Limited reported revenue of ₹68.03 Cr (up 54% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Ignoxlabs Private Limited
As of FY 2024, Ignoxlabs Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings Ignoxlabs Private Limited
Ignoxlabs Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Ignoxlabs Private Limited
Ignoxlabs Private Limited has a workforce of 357 employees as of Jan 05, 2026.
Employee Count & EPFO Data of Ignoxlabs Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Ignoxlabs Private Limited
GSTIN & GST Filing Data of Ignoxlabs Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Ignoxlabs Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Ignoxlabs Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Ignoxlabs Private Limited
MSME Payment Delays by Ignoxlabs Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Ignoxlabs Private Limited
Subsidiaries & Group Companies of Ignoxlabs Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Ignoxlabs Private Limited with ownership details.
MCA Filings & Documents of Ignoxlabs Private Limited
MCA Filings & Documents of Ignoxlabs Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Ignoxlabs Private Limited
Frequently Asked Questions about Ignoxlabs Private Limited
Ignoxlabs Private Limited is an active private limited company in the internet sector based in Gurgaon, Haryana, India. It was incorporated on 06 July 2017 (9+ years old) and is registered under CIN U85100HR2017PTC069799. The company has 357 employees.
Ignoxlabs Private Limited reported revenue of ₹68.03 Cr for FY 2025 (up 54.00% YoY).
The current directors of Ignoxlabs Private Limited are:
- Saumyajit Roy
- Manreet Kahlon
- Neha Khan
- Harsh Kumar Singh
The primary industry of Ignoxlabs Private Limited is internet. The company specifically operates in online healthcare services. The company is currently active in this sector.
Yes, Ignoxlabs Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Ignoxlabs Private Limited can be reached at the registered office: 2Nd Floor Unit No. 216 Ocus Quantum Sector 51, Gurgaon, Haryana, India – 122003, or through the website emoha.com.